NIH-funded research R21 grant

How gut bacteria affect liver cancer linked to metabolic disease

Official title: CROSSTALK BETWEEN GUT MICROBIOTA AND HEPATOCELLULAR CARCINOMA INDUCED BY METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE

Funded at Baylor College of Medicine · NIH-10952272 · Data updated 2026-11-12

This study is looking at how the bacteria in your gut might affect liver health and the risk of liver cancer for people with a specific liver condition called MASLD, hoping to find early signs that could help in preventing serious problems down the line.

More Carcinoma research and trials

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine
NIH-funded
Lab location1 site (Houston, United States)
Project startAugust 1, 2024
Project endJuly 31, 2026
Funding year2024
Award (this year)$426,425
NIH project number1R21CA293626-01
Project IDNIH-10952272 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with metabolic dysfunction-associated steatotic liver disease (MASLD) who are at risk for liver cancer.

Less likely to help

Patients without metabolic dysfunction or those who do not have liver disease may not benefit from this research.

What this research studies

This research investigates the relationship between gut microbiota and the development of liver cancer in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). The study aims to understand how changes in gut bacteria can lead to increased inflammation and liver damage, potentially resulting in cancer. By analyzing gut microbiota composition and its effects on liver health, the researchers hope to identify early indicators of liver cancer risk in these patients. This pilot study will lay the groundwork for larger studies in the future.

Why it matters

Potential benefit: If successful, this research could lead to improved early detection and treatment strategies for liver cancer in patients with metabolic diseases.

How similar studies have gone: Previous research has shown promising results in understanding the role of gut microbiota in various diseases, but this specific approach to liver cancer in MASLD is relatively novel.

Where this research is happening

  • Baylor College of Medicine
    Houston, United States
    Active

Researchers

  • Principal investigator: Jalal, Prasun Kumar — Baylor College of Medicine
  • Study coordinator: Jalal, Prasun Kumar

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.